Pacific Institute For Medica

The Pacific Heart Lung and Blood Institute (PHLBI) in Los Angeles, CA, was established in 2002 with a vision to rapidly develop innovative ideas into effective cancer therapies. The institute's mission is to generate hope through research support and education, focusing on heart disease, lung disease, blood disorders, and cancer, including mesothelioma. Led by a dedicated team including Dr. Robert B. Cameron and Nurse Lien, PHLBI is home to the Pacific Mesothelioma Center, offering resources, clinical trials, and a patient corner for those affected by mesothelioma. The institute also provides opportunities for research, licensing, and an international tissue bank, emphasizing a commitment to advancing medical knowledge and treatment options. Generated from the website

Now more than ever the Institute for Myeloma & Bone Cancer Research sees a vital need to focus an independent research effort to develop more effective therapies to improve the quality of life and longevity of patients with these catastrophic diseases. IMBCR president, Dr. James R. Berenson, has spent 28 years working closely on myeloma and bone cancer, and has been privileged to influence the advancement of treatment. This vast experience provides the cornerstone for The Institute for Myeloma & Bone Cancer Research and our dedication to this specific and crucial mission. IMBCR has assembled a renowned team of expert scientists who are dedicated to our research mission. Along with Dr. Berenson, Dr. Haiming Chen, directs the lab team continuing to lead the way to innovative therapies. With a high-level of understanding of these diseases, our expert team focuses on new and promising therapeutic approaches to help lengthen lives and relieve symptoms for patients. This makes our team unique in the world for having the ability to lead the science to revolutionize treatments, and hopefully someday, discover a cure. The Institute for Myeloma & Bone Cancer Research believes that there are key scientific areas in need of additional research effort, many of which are not being fully investigated by other laboratories or institutes. These include the following: Investigating the cross-talk behavior between the cancer cell and bone marrow. Current research focuses on killing the cancer cells that have already grown in the bone, or on rebuilding damaged bone. We have worked to understand the symbiotic relationship and found that there is a connection with the bone feeding the cancer. This opens new doors for research that could stop the cancer from growing in the first place by preventing this feeding by the bone. This would be revolutionary in helping curb the progression of the disease.

Huntington Medical Research Institutes is nonprofit, public-benefit organization dedicated to improving health and prolonging life by enhancing knowledge of life processes and disease and developing technology to diagnose and treat diseases. Its developments include the hydrocephalus shunt to treat water-on-the-brain, studies on biomedical applications of laser energy, cancer research, electronic neural rehabilitation technology and applications of medical magnetic resonance imaging and spectroscopy. Huntington Medical Research Institutes was founded in 1952 and operates in five locations in Pasadena, Calif.